Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,748 | -28,648 | -13,317 | -14,093 | N/A |
| Depreciation Amortization | 1,037 | 571 | 404 | 404 | N/A |
| Accounts receivable | 136 | -60 | -224 | 77 | N/A |
| Accounts payable and accrued liabilities | 348 | 507 | -174 | 145 | N/A |
| Other Working Capital | 503 | 2,162 | -240 | 726 | N/A |
| Other Operating Activity | 3,981 | 4,972 | 906 | 156 | 0 |
| Operating Cash Flow | $-33,743 | $-20,496 | $-12,645 | $-12,585 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,771 | -1,260 | -387 | -203 | N/A |
| Purchase Of Investment | -91,684 | -37,326 | N/A | N/A | N/A |
| Sale Of Investment | 54,826 | 0 | N/A | 4,017 | N/A |
| Other Investing Activity | 60 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-38,569 | $-38,586 | $-387 | $3,814 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,897 | 14,877 | 8,494 | 28,201 | N/A |
| Debt Repayment | -1,500 | -2,273 | -1,818 | -909 | N/A |
| Common Stock Issued | 66,068 | 69,617 | 7 | 3 | N/A |
| Other Financing Activity | -762 | -3,251 | 0 | 0 | 0 |
| Financing Cash Flow | $65,703 | $78,970 | $6,683 | $27,295 | $N/A |
| Beginning Cash Position | 37,393 | 17,505 | 23,854 | 5,330 | N/A |
| End Cash Position | 30,784 | 37,393 | 17,505 | 23,854 | N/A |
| Net Cash Flow | $-6,609 | $19,888 | $-6,349 | $18,524 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,743 | -20,496 | -12,645 | -12,585 | N/A |
| Capital Expenditure | -1,778 | -1,260 | -387 | -203 | N/A |
| Free Cash Flow | -35,521 | -21,756 | -13,032 | -12,788 | 0 |